Hudson Bay Capital Management
VIR icon

Hudson Bay Capital Management’s Vir Biotechnology VIR Stock Holding History

Hudson Bay Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.2M Buy
1,469,510
+144,510
+11% +$1.15M 0.08% 263
2025
Q4 		$7.99M Buy
1,325,000
+413,118
+45% +$2.46M 0.05% 384
2025
Q3 		$5.21M Buy
911,882
+215,882
+31% +$1.1M 0.03% 532
2025
Q2 		$3.51M Buy
696,000
+104,580
+18% +$561K 0.02% 647
2025
Q1 		$3.83M Sell
591,420
-258,453
-30% -$2.3M 0.02% 671
2024
Q4 		$6.24M Buy
849,873
+321,631
+61% +$2.54M 0.04% 458
2024
Q3 		$3.96M Buy
528,242
+103,242
+24% +$897K 0.03% 464
2024
Q2 		$3.78M Buy
425,000
+140,000
+49% +$1.34M 0.03% 425
2024
Q1 		$2.89M Sell
285,000
-5,000
-2% -$50.9K 0.03% 407
2023
Q4 		$2.92M Buy
290,000
+82,500
+40% +$754K 0.03% 393
2023
Q3 		$1.94M Buy
207,500
+197,500
+1,975% +$2.82M 0.02% 488
2023
Q2 		$245K Buy
+10,000
New +$251K ﹤0.01% 655

Other funds holding VIR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return